Free cash flow generation is highly unstable, with margins ranging from -3.1% to 5.5% over the last ten quarters, necessitating a reliance on $1.1 billion in acquisition-related cash inflows in 2026Q1 to support liquidity.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 |
|---|
| Cash from Operations | 126M | 543M | 480M | 210M | 300M | -131M | 2.18B | 385M | 274M | 773M | 1.14B | 921M | 1.61B | 1.09B | 1.28B | 1.26B | 1.19B | 1.08B | 1.06B | 687.74M | 350.25M | 411.05M | 325.75M | 243.7M | 285.5M | 154.39M | 22.98M | -11.75M |
| Operating CF Margin % | - | 4.35% | 3.8% | 1.68% | 2.46% | -1.06% | 18.47% | 2.91% | 1.94% | 5.03% | 6.17% | 4.74% | 8.66% | 8.38% | 9.83% | 10.6% | 10.43% | 8.89% | 9.75% | 9.65% | 8.02% | 11% | 9.77% | 8.6% | 12.97% | 9.12% | 1.72% | -1.09% |
| Operating CF Growth % | -334.24% | 13.13% | 128.57% | -30% | 329.01% | -106.01% | 465.71% | 40.51% | -64.55% | -32.01% | 23.45% | -42.97% | 48.34% | -14.95% | 1.44% | 6.16% | 10.43% | 1.81% | 53.73% | 96.35% | -14.79% | 26.19% | 33.67% | -14.64% | 84.92% | 571.69% | 295.68% | - |
| Net Income | -88M | 676M | -516M | -133M | 46M | 230M | 511M | -675M | -788M | -2.45B | -1.71B | 194M | 149M | 141.2M | 266.11M | 260.22M | 279.98M | 241.58M | 206.66M | 59.9M | 171.48M | 190.14M | 158.22M | 131.47M | 99.98M | 44.74M | 9.57M | -16.79M |
| Depreciation & Amortization | 435M | 426M | 486M | 505M | 534M | 540M | 558M | 608M | 700M | 861M | 1.1B | 1.17B | 1.18B | 782.67M | 725.56M | 652.67M | 609.84M | 566.21M | 499.08M | 332.58M | 188.77M | 164.56M | 158.38M | 143.77M | 118.22M | 119.67M | 97.62M | 81.65M |
| Stock-Based Compensation | 3M | 11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13K | 26K | 44K | 0 | 0 |
| Deferred Taxes | -235M | -243M | -116M | 35M | 165M | 170M | -187M | 203M | -3M | -454M | -116M | 103M | 107M | 69.28M | 53.41M | 107.03M | 97.37M | 34.27M | 159.87M | -39.89M | -25.23M | 9.89M | 41.9M | 61.57M | 38.17M | 25.28M | 17.21M | -3.8M |
| Other Non-Cash Items | -239M | -330M | 635M | 193M | 34M | 305M | -29M | 520M | 783M | 2.29B | 3.25B | 270M | 392M | 291.49M | 275.32M | 204.88M | 109.52M | 146.47M | 98.55M | 93.35M | 17.27M | 819K | -106K | 2.31M | 7.7M | 3.81M | -5.03M | -570K |
| Working Capital Changes | -335M | 3M | -9M | -390M | -479M | -1.38B | 1.32B | -271M | -418M | 525M | -177M | -818M | -214M | -195.93M | -40.27M | 37.1M | 92.02M | 87.9M | 93.12M | 241.81M | -2.04M | 45.64M | -32.65M | -95.43M | 21.4M | -39.16M | -96.46M | -86.32M |
| Change in Receivables | 6M | 99M | -66M | -193M | 22M | -136M | 309M | 93M | 31M | 732M | -96M | -219M | -306M | -285.44M | -204.15M | -138.33M | -27.05M | 58.39M | -57.44M | 131.3M | -71.14M | -47.45M | -31.81M | -150.84M | -19.1M | -22.94M | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.54M | -16.84M | -13.55M | -13.73M | -12.57M | 2M | -15.6M | -17.6M |
| Change in Payables | -267M | -36M | 137M | -50M | -158M | 16M | -67M | -157M | 0 | 0 | 0 | 0 | 147M | 72.47M | 246.3M | 246.11M | 161.95M | 86.1M | 119.6M | 125.96M | 52.15M | 84.96M | -23.29M | 34.72M | 26M | -26.95M | 0 | 0 |
| Cash from Investing | 1.43B | 847M | -277M | -22M | -251M | -543M | 191M | -3M | -273M | 1.07B | -608M | -1.04B | -4.35B | -991.27M | -1.38B | -1.2B | -1.04B | -867.18M | -665.47M | -7.5B | -640.26M | -327.27M | -318.48M | -620.77M | -291.14M | -265.11M | -244.44M | -155.54M |
| Capital Expenditures | -326M | -335M | -360M | -467M | -415M | -469M | -440M | -438M | -527M | -570M | -867M | -1.01B | -853M | -613.99M | -768.79M | -1.19B | -667.38M | -576.89M | -692.23M | -522.78M | -260.87M | -223.22M | -194.09M | -596.95M | -103.97M | -83.23M | -63.01M | -80.25M |
| CapEx % of Revenue | 1.52% | 2.68% | 2.85% | 3.74% | 3.4% | 3.79% | 3.73% | 3.32% | 3.72% | 3.71% | 4.7% | 5.2% | 4.58% | 4.72% | 5.9% | 10.01% | 5.86% | 4.76% | 6.39% | 7.33% | 5.98% | 5.97% | 5.82% | 21.06% | 4.73% | 4.91% | 4.71% | 7.43% |
| Acquisitions | 1.8B | 1.26B | 152M | 426M | 126M | 5M | 665M | 593M | 359M | 1.7B | 139M | 181M | -2.95B | -37.33M | -316.42M | 184.55M | -239.85M | -170.24M | 217.21M | -6.9B | -379.39M | -104.06M | -124.39M | 0 | 0 | -150.94M | -148.22M | -59.7M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -7M | -62M | 0 | 0 | 121M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -339.94M | 0 | 0 | -137.08M | -120.05M | -190.45M | -72.67M | 0 | 0 | 0 | -23.82M | -187.16M | -30.94M | -33.22M | -15.59M |
| Cash from Financing | -1.27B | -1.17B | -204M | -268M | -438M | -495M | -909M | -362M | -368M | -1.52B | -1.69B | -206M | 2.87B | -111.86M | 361.03M | -235.44M | -189.79M | -85.36M | -304.03M | 6.9B | 226.46M | -62.17M | 58.9M | 260.55M | 130.1M | 105.37M | 230.91M | 164.85M |
| Debt Issued (Net) | -1.08B | -1B | -48M | -123M | -305M | -369M | -794M | -322M | -1.07B | -1.52B | -1.86B | -158M | 2.88B | -440.61M | 130.14M | -92.65M | -61.48M | -58.26M | -106.78M | 6.9B | 380.78M | -26.84M | 357.06M | 275.16M | 137.34M | -197.89M | -284.25M | 165.41M |
| Equity Issued (Net) | -2M | -2M | -1M | -4M | -8M | -5M | -1M | -1M | -1M | -5M | -6M | -154M | 45M | 68.63M | 11.54M | -66.88M | -57.05M | 12.76M | -88.38M | 8.21M | -161.74M | -31.53M | -280.62M | -10.44M | 2.54M | 308.97M | 515.16M | -565K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.24M | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -2M | -2M | -1M | -4M | -8M | -5M | -1M | -1M | -1M | -5M | -6M | -179M | -20M | -42.03M | -9.31M | -85.79M | -113.96M | 0 | -90.19M | 0 | -176.32M | -79.85M | -290.52M | -14.71M | 0 | -91K | 0 | -2.78M |
| Other Financing | -186M | -165M | -155M | -141M | -125M | -121M | -114M | -39M | 701M | 5M | 174M | 106M | -48M | 260.12M | 241.88M | -75.91M | -71.27M | -39.87M | -108.87M | -4.43M | 7.42M | -3.8M | -17.54M | -4.16M | -9.79M | -5.71M | 0 | 0 |
| Net Change in Cash | 281M | 223M | -1M | -80M | -389M | -1.17B | 1.46B | 20M | -367M | 325M | 54M | -325M | 136M | -14.41M | 257.95M | -169.3M | -45.37M | 123.89M | 87.78M | 92.31M | -63.54M | 21.61M | 66.17M | -116.51M | 124.46M | -5.35M | 9.46M | -2.44M |
| Free Cash Flow | -200M | 208M | 120M | -257M | -115M | -600M | 1.74B | -53M | -253M | 203M | 1.49B | -89M | 762M | 474.73M | 511.33M | 69.83M | 521.35M | 499.54M | 365.05M | 164.95M | 125.74M | 222.68M | 161.46M | -353.25M | 181.52M | 71.16M | -40.02M | -92M |
| FCF Margin % | -0.93% | 1.67% | 0.95% | -2.06% | -0.94% | -4.85% | 14.74% | -0.4% | -1.79% | 1.32% | 8.08% | -0.46% | 4.09% | 3.65% | 3.92% | 0.59% | 4.57% | 4.13% | 3.37% | 2.31% | 2.88% | 5.96% | 4.84% | -12.46% | 8.25% | 4.2% | -2.99% | -8.52% |
| FCF Growth % | -231.58% | 73.33% | 146.69% | -123.48% | 80.83% | -134.52% | 3379.25% | 79.05% | -224.63% | -86.37% | 1773.03% | -111.68% | 60.51% | -7.16% | 632.2% | -86.61% | 4.37% | 36.84% | 121.3% | 31.19% | -43.54% | 37.92% | 145.71% | -294.6% | 155.11% | 277.8% | 56.5% | - |
| FCF per Share | -1.48 | 1.54 | 0.91 | -1.97 | -0.88 | -4.59 | 14.91 | -0.47 | -2.24 | 1.82 | 13.45 | -0.77 | 6.74 | 5.06 | 5.69 | 0.77 | 5.61 | 5.46 | 3.87 | 1.74 | 1.31 | 2.26 | 1.61 | -3.49 | 1.67 | 0.79 | -0.58 | -1.69 |
| FCF Conversion (FCF/Net Income) | 2.27x | 1.07x | -0.93x | -1.58x | 6.52x | -0.57x | 4.26x | -0.65x | -0.35x | -0.31x | -0.66x | 5.83x | 17.55x | 7.71x | 4.82x | 6.25x | 4.25x | 4.43x | 4.84x | 22.71x | 2.08x | 2.45x | 2.15x | 1.85x | 2.86x | 3.45x | 2.40x | 0.70x |
| Interest Paid | 215M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 91M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
High leverage and refinancing
As reported in recent financial filings, the relationship between net income and operating cash flow remains highly erratic, with the OCF/NI ratio swinging from -9.23 in 2025Q1 to 2.42 in 2025Q4, indicating that accounting accruals and non-cash charges frequently obscure the company's actual cash-generating capacity.
The persistent divergence between bottom-line results and cash flow suggests that reported net income is heavily influenced by non-recurring items and significant impairment charges. Investors should interpret these fluctuations as a sign that core operational cash flow is not reliably tracking with accounting profitability, complicating any assessment of true earnings quality.
Based on the provided quarterly data, CYH's free cash flow trajectory is characterized by extreme instability, with margins fluctuating between -3.1% and 5.5% over the last ten quarters, reflecting a business model that struggles to maintain consistent cash generation amidst ongoing portfolio rationalization and operational headwinds.
The inability to sustain positive free cash flow suggests that the company's capital requirements often outpace its operational inflows. This inconsistency warrants further investigation into whether the current divestiture strategy is successfully reducing the cash-burn profile or merely masking underlying structural inefficiencies in the remaining hospital network.
According to recent SEC filings, working capital changes have been a significant source of volatility for CYH, with a notable $347 million outflow in 2026Q1, suggesting that the company faces recurring challenges in managing its cash conversion cycle and timing of payments relative to patient service collections.
These sharp swings in working capital indicate potential friction in the revenue cycle, possibly tied to the timing of government reimbursements or shifts in payer mix. Such volatility in liquidity management may force the company to rely more heavily on external financing to bridge gaps during periods of negative working capital movement.
As reported in financial statements, CYH has utilized significant proceeds from asset sales, including $1.1 billion in 2026Q1, to manage its capital structure, highlighting a reliance on divestitures to offset operational cash shortfalls and address the company's substantial debt obligations in a high-interest rate environment.
The reliance on net acquisition proceeds to bolster cash flow suggests that the company is effectively liquidating its asset base to maintain solvency. While this provides immediate liquidity, it appears to be a defensive measure that limits future growth potential and leaves the company with a smaller, potentially less efficient operational footprint.
Quick answers to the most common questions about buying CYH stock.
Community Health Systems, Inc. (CYH) generated $543.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Community Health Systems, Inc. (CYH) generated $208.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Community Health Systems, Inc. (CYH) spent $335.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Community Health Systems, Inc. (CYH) spent $2.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.